Search

  • Sort by

  • Category

  • Post Type

  • Reset

Counterfeit Drugs: A Dangerous Threat to American Patients – Sources

October 18, 2013

The Partnership has released a new version of this publication. Please consult the 2017 edition here. This page collects the articles cited in the SAFEMEDICINES booklet Counterfeit Drugs: A Dangerous Threat to American Patients. Sources are listed by citation.  Each citation contains links to articles or reports, usually at their source. Because digital content is often moved or removed from the Internet…

Read More

Florida Man Sent to Prison for 2 Years for Selling Unapproved Imported Cancer Medication

October 18, 2013
Posted in ,

A Florida resident, Martin Paul Bean III has been sentenced to 2 years in prison in a complex counterfeit cancer drug scheme that purchased bulk cancer medications from Pakistan, India, and Turkey. The misbranded oncology drugs were then repackaged and sold as genuine, FDA-approved medications to medical practices throughout the United States. Repackaging work was done at a medical wholesaler…

Read More

Will the PSM 2013 Interchange Still Happen During the Government Shutdown?

October 16, 2013
Posted in ,

You can count on it. The criminals who counterfeit drugs and endanger American patients haven’t stopped making and selling fake drugs during the shutdown. There is more need for a counterfeit drug conference now than ever. The 2013 Interchange will include: Patient advocates who represent patients whose lives depend on getting genuine medication Journalists who chase down counterfeit drug supply…

Read More

New Research on Threats to the Secure Drug Supply Chain at 2013 Interchange

October 8, 2013
Posted in

2013 Interchange will feature new research from Carl L. Alsberg Fellow, Tim K. Mackey, and in-progress research from PSM Board member Marv Shepherd. As part of the Partnership for Safe Medicines continuing effort to inform the both the public and medical professionals about the dangers of counterfeit medication, we’re presenting two new research studies on how gaps in the supply…

Read More

Keynote Speaker Announced for Counterfeit Drug Conference

October 1, 2013
Posted in ,

The Partnership for Safe Medicines is pleased to announce Deputy Director Ilisa Bernstein as the keynote speaker of the 2013 Interchange on October 24, in Washington, DC. Dr. Ilisa Bernstein is the Deputy Director of Office of Compliance in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA). She works towards promoting and protecting…

Read More

Partnership For Safe Medicines India Holds Training Session Aimed at Combating Spurious Medication

September 27, 2013
Posted in

Partnership for Safe Medicines India brings together pharmaceutical, patient safety, and government enforcement organizations for their training workshop focused on protecting patients from false or spurious medicines. Bejon Misra, founder of the Partnership for Safe Medicines India will be our luncheon speaker at the 2013 Interchange October 24th in Washington D.C. Register today! On August 23rd 2013, the Partnership for Safe Medicines…

Read More

PSM’s Scott LaGanga to Japan Medical Association: Counterfeit Medicines a Global Health Menace

September 23, 2013
Posted in ,

PSM Executive Director Urges Greater International Cooperation in Major Address to the Japan Medical Association TOKYO, JAPAN (September 19, 2013) – Partnership for Safe Medicines Executive Director Scott LaGanga stressed the urgent need for greater global education and collaboration to fight the growing health threat posed by counterfeit and substandard medicines in an address to the Japan Medical Association (JMA).…

Read More

Shepherd M*. Examination of Why Some Community Pharmacists Do Not Provide 72-Hour Emergency Prescription Drugs to Medicaid Patients When Prior Authorization Is Not Available. J Manag Care Pharm. 2013;19(7):523-33.

September 19, 2013
Posted in , , , , ,

BACKGROUND: Existing federal law requires that a 72-hour emergency supply of a prescription drug be dispensed to Medicaid patients when prior authorization (PA) is not available and the medication is needed without delay. The pharmacist’s role is to contact prescribers and inform them that PA is needed. If the prescriber cannot be reached, the pharmacist can dispense a 72-hour emergency supply.

OBJECTIVES: To determine (a) the reasons why some community pharmacy owners/managers, staff pharmacists, and technicians are not compliant with the law; (b) how often the decision is made; and (c) estimate how often pharmacies do not dispense the 72-hour emergency supply when PA is not available.

Read More

Is it Safe For Americans to Order Life-Saving Medicine From Online Pharmacies Overseas?

September 18, 2013
Posted in ,

Click image to download G-8 Infographic (pdf) The countries of the Group of 8 (G8) have begun to work together to try and fight the global scourge of counterfeit medications. Their efforts are important, as most of the G8 member countries are having their own problems with counterfeit drug crime. In May 2013 leaders from the G8 countries agreed “to…

Read More

U.S. Pharmacopeial Convention Sets Up New Counterfeit Drug Detection Training Facility in Ghana

September 11, 2013
Posted in

We are pleased to welcome Dr. Lukulay as a speaker at PSM’s 2013 Interchange, happening October 24th in Washington D.C. Register now to hear about the achievements of the U. S. Pharmacopeial Convention and Dr. Lukulay in combatting counterfeit medication in Africa. In May 2013, the US Pharmacopeial Convention(USP) achieved their long-held goal of opening a counterfeit drug testing training…

Read More